Drug Pipeline

Intravenous immunoglobulin (IVIG) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
4
Recruiting
3
Phase 3
7
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT06925360
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia		 Primary endpoint(s) modified
Active Studies by Phase
Phase 3
2
Phase 2/3
1
Phase 2
5
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06954441 V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency Immunodeficiencies Recruiting
NCT07299695 Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic… Idiopathic Pulmonary Fibrosis Recruiting
Phase 2/3
NCT02205762 LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With… Langerhans Cell Histiocytosis Active, Not Recruiting
Phase 2
NCT07561125 Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below Bronchopulmonary Dysplasia Recruiting
NCT06925360 IVIG Trial for the Treatment of Bronchopulmonary Dysplasia Bronchopulmonary Dysplasia Recruiting
NCT05156710 BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) Transplant Rejection Active, Not Recruiting
NCT05662228 Therapies for Down Syndrome Regression Disorder Down Syndrome Active, Not Recruiting
NCT03194815 IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 Psychosis Active, Not Recruiting
Sponsors Running Intravenous immunoglobulin (IVIG) Trials
International Peace Maternity and Child Health Hospital (2) North American Consortium for Histiocytosis (1) University of Cambridge (1) Sanofi (1) University of Colorado, Denver (1) On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. (1) Argyrios Tzouvelekis (1)
Disease Areas
Idiopathic Pulmonary Fibrosis (1)
Get alerts when Intravenous immunoglobulin (IVIG) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free